Peptonic Medical

PEPTONIC medical is developing an estrogen-free treatment for vaginal atrophy. The patented product is based on local, vaginal application of oxytocin.

Peptonic’s vision is to make the naturally occurring hormone, oxytocin, the leading treatment for women suffering from vaginal atrophy during menopause and after. To date, four clinical studies have been performed. Three of these were randomized, double-blind and placebo controlled. The studies have shown positive effects of the new oxytocin based treatment on local signs of vaginal atrophy within the vaginal wall and a reduction of bothersome symptoms.